Evaluation of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy in immunotherapy-associated systemic reactions

被引：8
|
作者：
Carlson, Geoffrey S. [1 ]
Wong, Priscilla H.
White, Kevin M. [2 ]
Quinn, James M. [1 ]
机构：
[1] Wilford Hall, Lackland AFB, TX USA
[2] Royal Air Force Lakenheath, Brandon, England
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2017年 / 5卷 / 05期
关键词：
VENOM; MEDICATION; SAFETY;
D O I：
10.1016/j.jaip.2017.05.009
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1430 / 1432
页数：3
相关论文
共 50 条
  • [31] Clinical Value of Angiotensin-converting Enzyme Inhibitor and Angiotensin Receptor Blocker in the Patients of Coronary Artery Disease
    Abe, Daisuke
    Sato, Akira
    Misaki, Masako
    Takeyasu, Noriyuki
    Hoshi, Tomoya
    Aonuma, Kazutaka
    CIRCULATION, 2013, 128 (22)
  • [32] Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril
    G Bönner
    G L Bakris
    D Sica
    M A Weber
    W B White
    A Perez
    C Cao
    A Handley
    S Kupfer
    Journal of Human Hypertension, 2013, 27 : 479 - 486
  • [33] Can an Angiotensin Receptor Blocker Be Used in a Patient in Whom Angioedema Developed With an Angiotensin-Converting Enzyme Inhibitor?
    Cohen, Debbie L.
    Townsend, Raymond R.
    JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (12): : 949 - 950
  • [34] Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
    Rossato, Marco
    Di Vincenzo, Angelo
    EUROPEAN CARDIOLOGY REVIEW, 2020, 15
  • [35] ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR THERAPY
    OPIE, LH
    PRZYBOJEWSKI, JZ
    SOUTH AFRICAN MEDICAL JOURNAL, 1992, 81 (04): : 183 - 185
  • [36] Olmesartan is an angiotensin II receptor blocker with an inhibitory effect of angiotensin-converting enzyme
    Agata, Jun
    Ura, Nobuyuki
    Yoshida, Hideaki
    Shinshi, Yasuyuki
    Sasaki, Haruki
    Hyakkoku, Masaya
    Taniguchi, Shinya
    Shimamoto, Kazuaki
    JOURNAL OF HYPERTENSION, 2006, 24 : 208 - 208
  • [37] Olmesartan Is an Angiotensin II Receptor Blocker with an Inhibitory Effect on Angiotensin-Converting Enzyme
    Jun Agata
    Nobuyuki Ura
    Hideaki Yoshida
    Yasuyuki Shinshi
    Haruki Sasaki
    Masaya Hyakkoku
    Shinya Taniguchi
    Kazuaki Shimamoto
    Hypertension Research, 2006, 29 : 865 - 874
  • [38] Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme
    Agata, Jun
    Ura, Nobuyuki
    Yoshida, Hideaki
    Shinshi, Yasuyuki
    Sasaki, Haruki
    Hyakkoku, Masaya
    Taniguchi, Shinya
    Shimamoto, Kazuaki
    HYPERTENSION RESEARCH, 2006, 29 (11) : 865 - 874
  • [39] SYSTEMIC REACTIONS TO INTRAVENOUS IRON THERAPY IN PATIENTS RECEIVING ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    ROLLA, G
    BUCCA, C
    BRUSSINO, L
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (06) : 1074 - 1075
  • [40] Angiotensin-Converting Enzyme Inhibitor (ACEI) and Angiotensin Receptor Blocker (ARB) Use are Associated With Increased Readmission After Ileostomy Creation
    Gan, Connie Y.
    Rahman, Shahrose
    Flerchinger, Shaun R.
    Barton, Jeffrey S.
    AMERICAN SURGEON, 2025, 91 (04) : 556 - 560
12345